Wiley Bros. Aintree Capital, LLC Evotec Se Transaction History
Wiley Bros. Aintree Capital, LLC
- $14.9 Billion
- Q3 2025
Shares
1 transactions
Others Institutions Holding EVO
# of Institutions
37Shares Held
4.06MCall Options Held
0Put Options Held
0-
Wellington Management Group LLP Boston, MA1.43MShares$4.32 Million0.0% of portfolio
-
Dcf Advisers, LLC Greenwich, CT1.2MShares$3.62 Million1.96% of portfolio
-
Morgan Stanley New York, NY315KShares$951,0340.0% of portfolio
-
Wcm Investment Management, LLC Laguna Beach, CA300KShares$906,8360.0% of portfolio
-
Pitcairn CO Jenkintown, PA162KShares$488,5420.05% of portfolio
About Evotec SE
- Ticker EVO
- Exchange OTC
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 353,904,992
- Market Cap $1.07B
- Description
- Evotec SE operates as drug discovery and development partner for the pharmaceutical and biotechnology industry worldwide. The company is developing pharmaceutical products in various therapeutic areas, such as diabetes and complications of diabetes, fibrosis, infectious diseases, CNS diseases, oncology, pain and inflammation, immunology, rare di...